π Biologic Therapies (e.g., IL-17/IL-23 Inhibitors) Cost in Korea
Biologic therapies targeting interleukin pathways, such as IL-17
and IL-23 inhibitors(e.g., Secukinumab, Ixekizumab, Guselkumab), are highly advanced treatments used in Korea for moderate to severe psoriasis and psoriatic arthritis. These therapies are designed to precisely block specific immune responses causing inflammation, offering effective control with fewer systemic side effects.
π Comprehensive Cost Overview
| Biologic Type |
Cost per Injection (KRW) |
Treatment Purpose |
| IL-17 Inhibitors (e.g., Secukinumab) |
1,200,000 – 2,000,000 |
Psoriasis, psoriatic arthritis |
| IL-23 Inhibitors (e.g., Guselkumab) |
1,500,000 – 2,200,000 |
Plaque psoriasis, inflammatory skin disease |
π§Ύ Detailed Cost Analysis by Component
| Component |
Estimated Price (KRW) |
Details |
| Initial Consultation |
30,000 – 60,000 |
Diagnosis and eligibility assessment |
| Biologic Injection (per dose) |
1,200,000 – 2,200,000 |
Drug cost varies by type and brand |
| Administration Fee |
30,000 – 80,000 |
Hospital or clinic administration |
β Additional & Optional Services Cost
| Service |
Estimated Cost (KRW) |
Purpose |
| Blood Tests & Monitoring |
40,000 – 120,000 |
Baseline screening and follow-ups |
| TB/Screening Tests |
20,000 – 60,000 |
Mandatory before treatment starts |
π₯ Clinical Treatment Costs
| Clinic Type |
Price Range (KRW) |
Inclusions |
| Private Dermatology Clinic |
1,300,000 – 2,400,000 |
Consultation + Injection + Follow-up |
| University Hospital (Tertiary) |
1,500,000 – 2,700,000 |
Advanced biologic protocol with tests |
